Delivery Order SPE2DB22D1017-SPE2DB25FH0AE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100 count units) with a ceiling value of $2,047.19. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. No set-aside designation was used for this award, indicating...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count units) with a contract value of $1,525.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. As a child...
- The Defense Logistics Agency awarded a $1,111.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count). This delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,364.82 by the Defense Logistics Agency's Medical Supply Chain division on August 15, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. The order, which is not set-aside and was competitively awarded at firm fixed pricing, is scheduled for completion by August 18, 2025, with performance originating from the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,242.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,442.92 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a ceiling value of $4,221.50. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0AEDelivery Order
The Defense Logistics Agency awarded a $1,437.63 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which functions as a global pharmaceutical support vehicle enabling the delivery of a comprehensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities. This delivery order for Lisdexamfetamine exemplifies the company's role in fulfilling Department of Defense pharmaceutical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/18/25 |